BRAINLIFE Brain Tumor Medical Database

Cyclophosphamide

Home > Database > Treatment > Cyclophosphamide

Contents


Embryonal Tumors


Bevacizumab, Celecoxib,  Cyclophosphamide, Etoposide, Fenofibrate, Thalidomide

Peyrl A, Chocholous M, Kieran MW, Azizi AA, Prucker C, Czech T, Dieckmann K, Schmook MT, Haberler C, Leiss U, Slavc I.
Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors.
Pediatr Blood Cancer. 2011 Dec 6;. [Epub ahead of print]
  Abstract |   Related articles


Germ Cell Tumors


Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol
J Clin Oncol. 2004 Mar 1;22(5):846-53.


Gliomas (Low-Grade)


Mee Jeong Lee, Young Shin Ra, Jun Bum Park, Hyun Woo Goo, Seung Do Ahn, Shin Kwang Khang, Joon Sup Song, Yoon Jung Kim and Thad T. Ghim
Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children
Journal of Neuro-Oncology, Volume 80, Number 3 / December, 2006, Pages 277-284, Published online: 29 June 2006


Malignant Lymphoma


Brian Patrick O'Neill, Judith Rich O'Fallon, Stephen S Cha, Paul J Kurtin, Bernd W Scheithauer, Paul D Brown, Thomas A Habermann, Fernando K Addo, Mark Gilbert
Newly diagnosed primary central nervous system lymphoma (PCNSL): initial report of North Central Cancer Treatment Group (NCCTG)/Eastern Cooperative Oncology Group (ECOG) protocol 93 73 51
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
2074


Medulloblastoma


Alba A Brandes, Mario Ermani, Pietro Amista, Umberto Basso, Francesca Vastola, Antonino Rotilio, Carlo Mazza, Franco Ammannati, Bianca Guglielmi, Franco Berti
A prospective study on medulloblastoma (MB) in adults
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract No.
301

Amar Gajjar MD, Murali Chintagumpala MD, David Ashley MBBS, Stewart Kellie MBBS, Prof Larry E Kun MD, Prof Thomas  E Merchant DO, Shaio Woo MD, Greg Wheeler MBBS, Valerie Ahern MBBS, Matthew J Krasin MD, Maryam Fouladi MD, Alberto Broniscer MD, Prof Robert Krance MD, Gregory A Hale MD, Clinton F Stewart PharmD, Robert Dauser MD, Prof Robert A Sanford MD, Christine Fuller MD, Ching Lau MD, Prof James M Boyett PhD, Dana Wallace MS and Richard J Gilbertson MD
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Lancet Oncology Early Online Publication, 7 September 2006, DOI:10.1016/S1470-2045(06)70867-1
Abstract / BrainLife |
News  News

Kadota RP, Mahoney DH, Doyle J, Duerst R, Friedman H, Holmes E, Kun L, Zhou T, Pollack IF.
Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma
Pediatr Blood Cancer. 2008 Jul 11; [Epub ahead of print]
 Abstract


Metastatic Tumors


Colleoni M, Rocca A, Sandri MT, Zorzino L, Masci G, Nole F, Peruzzotti G, Robertson C, Orlando L, Cinieri S, de BF, Viale G, Goldhirsch A
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels
Ann Oncol 2002 Jan;13(1):73-80

Hong JJ, Rosenberg SA, Dudley ME, Yang JC, White DE, Butman JA, Sherry RM
Successful Treatment of Melanoma Brain Metastases With Adoptive Cell Therapy
Clin Cancer Res. 2010 Aug 23. [Epub ahead of print]
  Abstract

Laura Orlando, Anna Cardillo, Raffaella Ghisini, Andrea Rocca, Alessandra Balduzzi, Rosalba Torrisi, Giulia Peruzzotti, Aron Goldhirsch, Elisabetta Pietri, and Marco Colleoni
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer
BMC Cancer. 2006 Sep 15;6:225
Abstract | Full Text | Reprint


Neuroblastoma


A. Donfrancesco, A. Jenkner, A. Castellano, I. Ilari, G. M. Milano, C. Dominici, L. De Sio, P. Fidani
Front-line topotecan and high-dose cyclophosphamide followed by ICE in high-risk neuroblastoma
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8536

C. N. Frantz, W. B. London, L. Diller, R. Seeger, K. Sawyer
Recurrent neuroblastoma: Randomized treatment with topotecan + cyclophosphamide (T+C) vs. topotecan alone(T). A POG/CCG Intergroup Study
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8512

H Rubie, C Coze, D Plantaz, C Munzer, A S Defachelles, C Bergeron, C Thomas, P Chastagner, D Valteau-Couanet, J Michon, V Mosseri and O Hartmann
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy
British Journal of Cancer3 November 2003, Volume 89, Number 9, 1605-1609


Non-Nervous System T.


Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O'Reilly MS, Folkman J
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer
Cancer Res 2000 Apr 1;60(7):1878-86 (PDF Full Text)

Man S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ, Bergers G, Kerbel RS
Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water
Cancer Res 2002 May 15;62(10):2731-5 


Paraneoplastic Neur. Dis.


Steven Vernino, Brian Patrick O’Neill, Randolph S. Marks, Judith R. O’Fallon, and David W. Kimmel
Immunomodulatory treatment trial for paraneoplastic neurological disorders
Neuro-Oncology, January 2004, Volume 6, Number 1, Pages: 55 -- 62 (Abstract+)

 

This website is certified by Health On the Net Foundation. Click to verify. HOMEARCHIVES OF NEURO-ONCOLOGYCURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTS
SERVICES: About BrainLife | Brain Tumor Medical Database | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications

This site complies with the HONcode standard for trustworthy health information: verify here bottom